AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet

Intensive Care Med. 2018 Jul;44(7):1156-1158. doi: 10.1007/s00134-018-5151-7. Epub 2018 Apr 12.

Harm-Jan de Grooth¹, Jean-Jacques Parienti^{2

3}, Miet Schetz⁴

¹ Department of Intensive Care, VU University Medical Center, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands.
² Department of Biostatistics and Clinical Research, Centre Hospitalo-Universistaire de Caen, Caen, France.
³ EA2656 Groupe de Recherche sur l'Adaptation Microbienne, Université Caen Normandie, Caen, France.
⁴ Clinical Department and Laboratory of Intensive Care Medicine, Division of Cellular and Molecular Medicine, KU Leuven University, Herestraat 49, 3000, Leuven, Belgium. [email protected].

No abstract available

Publication types